Recombinant Zoster (Shingles) Vaccine: SHINGRIX

Recombinant shingles vaccine is the preferred vaccine for the prevention of shingles. This vaccine is recommended for adults 50 years and older without serious immune problems. It is given as a two-dose series, two months apart. A sore arm with moderate pain is very common, affecting about 80% of vaccinated people. Redness and swelling can also happen at the site of the injection. For more information please follow this link: https://www.cdc.gov/vaccines/hcp/vis/vis-statements/shingles-recombinant.pdf